Fabry disease is an X-linked lysosomal storage disorder caused by mutations in the GLA gene, leading to deficient activity of the enzyme α-galactosidase A. This enzymatic defect results in progressive accumulation of globotriaosylceramide (Gb3) and its deacetylated derivative lyso-Gb3, affecting multiple organ systems, particularly the heart, kidneys, nervous system, and vascular endothelium.1,2. Here, GLA is linked to Fabry disease.